Shire returns Adept rights

Shire (LSE:SHP; SHPGY) will return European marketing rights to Adept icodextrin to ML Labs (LSE:MLB) effective Dec. 30. The drug is approved in the EU to reduce post-operative abdominal adhesions; it...